The latest thoracic oncology news
Mesothelioma: Triple combination therapy shows promise
Combining immune-boosting drugs with radiation and surgery increased the survival and anticancer immune response in…
Browsing: Lung Cancer
AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial
Adding nivolumab to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer…
AACR 2021: Level of chromosomal abnormality in lung cancer may predict immunotherapy response
Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy…
AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer
Lower levels of cancer aneuploidy were associated with more favourable outcomes after immune checkpoint inhibition…
Scientists identify potential new target for lung cancer treatment
In cancer, personalised medicine takes advantage of the unique genetic changes in an individual tumour…
High expression of cell death genes associated with early death from lung cancer
Patients with a high number of genes most associated with pathways that lead to cell…
Risk prediction to reduce minority disparities in US lung cancer screening guidelines
According to ARRS’ American Journal of Roentgenology (AJR), updated United States Preventive Services Task Force…
AI used against asbestos-linked cancer
International genomics research led by the University of Leicester, UK, has used artificial intelligence (AI)…
Lymph node collection kit may improve long-term survival after lung cancer surgery
A lymph node collection kit can help surgeons attain compete resection and improve long-term survival…
Second drug targeting KRASG12C shows benefit in mutated non-small-cell lung cancer
Clinical activity with a second drug inhibiting KRASG12C confirms its role as a therapeutic target…